Please confirm you are human

This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.

A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.

Hold with a pointer, or hold Space or Enter.

News

AI Insider
theaiinsider.tech > 08/19/2026 > sandboxaq-aqpotency-drug-discovery

SandboxAQ Launches AQPotency for Drug-Target Screening

1+ hour, 55+ min ago   (179+ words) AQPotency also works in the other direction. Starting with a single promising molecule, it scans a broad panel of proteins across the body and returns a ranked list of the ones it is most likely to act on. When a…...

EdexLive
edexlive.com > news > researchers-at-iisc-bengaluru-combine-evolutionary-biology-and-artificial-intelligence-to-design-broad-spectrum-antivenom

Researchers at IISc Bengaluru combine evolutionary biology and artificial intelligence to design broad-spectrum antivenom

3+ hour, 9+ min ago   (371+ words) Kolkata, Aug 19 (IANS): The Indian Institute of Science (IISc), Bengaluru, is using artificial intelligence (AI) to develop broadly neutralising anti-venoms capable of treating bites from multiple snake species, potentially addressing a major public health challenge that claims tens of thousands…...

MLex
mlex.com > mlex > amp > articles > 2515230

As Big Pharma patents age, smaller biotechs hold the most clinical-stage assets

6+ hour, 12+ min ago   (32+ words) MLex As Big Pharma patents age, smaller biotechs hold the most clinical-stage assets To view the full article, register now....

National Academies of Sciences
nationalacademies.org > news > inaugural-cohort-of-biotechnology-regulatory-fellows-present-capstone-projects

Inaugural Cohort of Biotechnology Regulatory Fellows Present Capstone Projects

4+ hour, 55+ min ago   (140+ words) Last update August 19, 2026 what neural organoid models might reveal about the regulatory readiness of new approach methodologies (NAMs); aligning competing incentives in gene therapy manufacturing to move the field toward a platform-based approach; the scientific knowledge needed to assess microbial…...

News-Medical
news-medical.net-medical.net

Industrial-scale proteomics for drug discovery

4+ hour, 7+ min ago   (337+ words) As a result, the pharmaceutical and biotech sectors have shown increasing interest in molecular glues, targeted protein degraders (TPD), targeted protein stabilizers (TPS), and targeted covalent ligands. Evotec employs the latest versions of automated and multiplexed sample preparation, combined with…...

Carroll County Mirror-Democrat
mycarrollcountynews.com > online_features > press_releases > article_fd97cbe1-af45-5c9b-92b6-f6573b7f9558.html

Neuroscience Antibodies & Assays Market Intelligence Report Covers Trends, Segments And Regional Growth

8+ hour, 42+ min ago   (238+ words) The Business Research Company's Neuroscience Antibodies & Assays Market Intelligence Report Covers Trends, Segments And Regional Growth LONDON, GREATER LONDON, UNITED KINGDOM, August 19, 2026 /EINPresswire.com/ -- "The neuroscience antibodies and assays sector is experiencing swift advancement, driven by growing research efforts and…...

ROI-NJ
roi-nj.com-nj.com

GenScript says AI drug discovery business doubled in report of first half revenue growth

4+ hour, 54+ min ago   (237+ words) ROI-NJ GenScript says AI drug discovery business doubled in report of first half revenue growth Sherry Shao, rotating CEO. - GenScript Biotech Corp. GenScript Biotech Corp. of Piscataway said Aug. 18 that its first-half revenue increase of more than 27% to $404.2 million was…...

Google News
natlawreview.com > press-releases > genbio-inc-highlights-strategic-importance-emerging-biotechnology-amid

GenBio Inc. Highlights Strategic Importance of Emerging Biotechno

5+ hour, 8+ min ago   (160+ words) Built On Science Guided By Evidence Prepared For Partnership Peter Ferdinand Drucker was an Austrian-born American management consultant, educator, and author widely regarded as the father of modern management $500 Billion Is Flowing Into U.S. Pharmaceutical Infrastructure GenBio highlights the convergence of…...

Google News
marketscreener.com > news > most-ai-drug-discovery-reads-the-genetic-code-the-next-wave-is-learning-to-read-what-the-code-actua-ce7859d2db8ff724

Most AI Drug Discovery Reads the Genetic Code. The Next Wave Is Learning to Read What the Code Actually Does.

6+ hour, 58+ min ago   (122+ words) Published on 08/19/2026 at 08:56 am EDT Closing the Loop Between Code and Lab Why Big Pharma Is Paying Attention AbCellera Biologics Inc. (Nasdaq: ABCL) Absci Corporation (Nasdaq: ABSI) Eli Lilly and Company (NYSE: LLY) AstraZeneca PLC (NYSE: AZN) Track the Signals…...

AI CERTs News
aicerts.ai > news > aureka-secures-100m-to-scale-ai-drug-discovery-platform

Aureka Secures $100M to Scale AI Drug Discovery Platform

10+ hour, 42+ min ago   (174+ words) This report delivers that guidance and examines what Aureka’s raise means for future therapeutic discovery. Additionally, it outlines how specialists can upskill with recognised certifications. Read on for detailed analysis, benchmarks, and strategic implications. 19 August 26 at 2:42 pm 19 August 26 at 2:38 pm…...